Literature DB >> 15459768

Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions.

Daniel Schlittenhardt1, Andreas Schober, Jens Strelau, Gabriel A Bonaterra, Walther Schmiedt, Klaus Unsicker, Jürgen Metz, Ralf Kinscherf.   

Abstract

Growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) is a new member of the transforming growth factor beta (TGF-beta) superfamily, which has most recently been found in activated macrophages (MPhi). We have now investigated GDF-15/MIC-1 in human MPhi after exposure to oxidized low-density lipoproteins (oxLDL) related mediators in vitro and in arteriosclerotic carotid arteries. Using RT-PCR and Western blotting a pronounced induction of GDF-15/MIC-1 expression by oxLDL, C6-ceramide, tumor necrosis factor (TNFalpha) and hydrogen peroxide (H2O2) was found in cultured human MPhi. In 11 human arteriosclerotic carotid arteries, immunohistochemical analyses supported by computer-assisted morphometry and regression analyses demonstrated a significant colocalization of GDF-15/MIC-1 immunoreactivity (IR) with oxLDL IR and manganese superoxide dismutase (MnSOD) IR in CD68 immunoreactive (ir) MPhi, which were also expressing AIF-IR (apoptosis-inducing factor), caspase-3-IR (CPP32), PARP-IR, c-Jun/AP-1-IR and p53-IR. Our data suggest that GDF-15/MIC-1 is inducible in human MPhi by oxLDL and its mediators in vitro and is supposed to contribute to oxidative stress dependent consequences in arteriosclerotic plaques, e.g. modulating apoptosis and inflammatory processes in activated MPhi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459768     DOI: 10.1007/s00441-004-0986-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  71 in total

1.  Mechanisms of crystalline silica-induced pulmonary toxicity revealed by global gene expression profiling.

Authors:  Rajendran Sellamuthu; Christina Umbright; Shengqiao Li; Michael Kashon; Pius Joseph
Journal:  Inhal Toxicol       Date:  2011-11-16       Impact factor: 2.724

Review 2.  Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population.

Authors:  Kamal Shemisa; Anish Bhatt; Daniel Cheeran; Ian J Neeland
Journal:  Curr Heart Fail Rep       Date:  2017-08

3.  Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.

Authors:  Anand Rohatgi; Parag Patel; Sandeep R Das; Colby R Ayers; Amit Khera; Abelardo Martinez-Rumayor; Jarett D Berry; Darren K McGuire; James A de Lemos
Journal:  Clin Chem       Date:  2011-11-07       Impact factor: 8.327

Review 4.  The development of gene therapy for diseases of the lung.

Authors:  D R Gill; L A Davies; I A Pringle; S C Hyde
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

5.  Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort.

Authors:  Amy S You; Kamyar Kalantar-Zadeh; Lorena Lerner; Tracy Nakata; Nancy Lopez; Lidia Lou; Mary Veliz; Melissa Soohoo; Jennie Jing; Frank Zaldivar; Jeno Gyuris; Danh V Nguyen; Connie M Rhee
Journal:  Cardiorenal Med       Date:  2017-02-02       Impact factor: 2.041

Review 6.  Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Trends Cardiovasc Med       Date:  2016-07-28       Impact factor: 6.677

7.  Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Authors:  Thomas J Wang; Kai C Wollert; Martin G Larson; Erin Coglianese; Elizabeth L McCabe; Susan Cheng; Jennifer E Ho; Michael G Fradley; Anahita Ghorbani; Vanessa Xanthakis; Tibor Kempf; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan; James L Januzzi
Journal:  Circulation       Date:  2012-08-20       Impact factor: 29.690

8.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

9.  Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.

Authors:  Maria Lajer; Anders Jorsal; Lise Tarnow; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 17.152

10.  Eupatilin protects gastric epithelial cells from oxidative damage and down-regulates genes responsible for the cellular oxidative stress.

Authors:  Eun-Ju Choi; Hyun-Mee Oh; Bo-Ra Na; T P Ramesh; Hyun-Ju Lee; Chang-Soo Choi; Suck-Chei Choi; Tae-Young Oh; Suck-Jun Choi; Jeong-Ryong Chae; Sang-Wook Kim; Chang-Duk Jun
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.